We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

28 hedge funds and large institutions have $45.1M invested in Global Cord Blood Corporation in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

4% more call options, than puts

Call options by funds: $50K | Put options by funds: $48K

0% more funds holding

Funds holding: 2828 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

5% less capital invested

Capital invested by funds: $47.7M → $45.1M (-$2.55M)

Holders
28
Holders Change
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
9
Reduced
7
Closed
7
Calls
$50K
Puts
$48K
Net Calls
+$2K
Net Calls Change
+$163K
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$2K -$314 -74 -15%
OA
27
Operose Advisors
Wisconsin
$1K +$849 +200 New
Barclays
28
Barclays
United Kingdom
-$957K -204,942 Closed
Millennium Management
29
Millennium Management
New York
-$102K -21,800 Closed
MFW
30
Mosaic Family Wealth
Missouri
-$57K -12,275 Closed
FCI
31
Financial Counselors Inc
Kansas
-$47K -10,133 Closed
GLLW
32
Graves Light Lenhart Wealth
Virginia
-$9K -2,001 Closed
UBS Group
33
UBS Group
Switzerland
-$2K -413 Closed

CO Hedge Fund Activity: Q4 2021 in Review

28 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2021, worth a combined $45.1M — down 5.3% from $47.7M a quarter earlier.

Fund positioning in CO was balanced in Q4 2021: 7 funds opened new positions, 7 closed out, 9 added to existing stakes and 7 trimmed.

The largest buyer was Oasis Management Company, adding an estimated $1.7M. The largest seller was Barclays, exiting entirely with an estimated $957K sold.

  • 28 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $45.1M of Global Cord Blood Corporation stock for Q4 2021, down 5.3% quarter-over-quarter.
  • 7 funds opened new Global Cord Blood Corporation positions in Q4 2021 and 7 closed out, a net change of 0 holders.
  • The largest Global Cord Blood Corporation buyer in Q4 2021 was Oasis Management Company, an estimated $1.7M added.
  • The largest Global Cord Blood Corporation seller in Q4 2021 was Barclays, an estimated $957K sold.

Based on aggregated 13F filings for Q4 2021.